Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Preusser

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
The Journal of Infusional Chemotherapy|July 1, 1996
Weekly infusional 5-fluorouracil plus/minus other drugs for the treatment of advanced gastric cancerH Wilke, M Korn, U Vanhöfer, et al.
Seminars in Oncology|April 1, 1992
Biochemical modulation of 5-fluorouracil by folinic acid or alpha-interferon with and without other cytostatic drugs in gastric, esophageal, and pancreatic cancerH Wilke, M Stahl, H J Schmoll, et al.
British Journal of Cancer|September 11, 2003
Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trialC-H Köhne, R Catane, B Klein, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1983
Adjuvant chemotherapy in osteosarcoma - effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 studyK Winkler, G Beron, R Kotz, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
The Journal of Infusional Chemotherapy|July 1, 1996
Weekly infusional 5-fluorouracil plus/minus other drugs for the treatment of advanced gastric cancerH Wilke, M Korn, U Vanhöfer, et al.
Seminars in Oncology|April 1, 1992
Biochemical modulation of 5-fluorouracil by folinic acid or alpha-interferon with and without other cytostatic drugs in gastric, esophageal, and pancreatic cancerH Wilke, M Stahl, H J Schmoll, et al.
British Journal of Cancer|September 11, 2003
Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trialC-H Köhne, R Catane, B Klein, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1983
Adjuvant chemotherapy in osteosarcoma - effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 studyK Winkler, G Beron, R Kotz, et al.
Pageof 5